Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
0.850
-0.093 (-9.84%)
Dec 20, 2024, 4:00 PM EST - Market closed
Processa Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Cash & Equivalents | 2.89 | 4.71 | 6.5 | 16.5 | 15.42 | 0.69 | Upgrade
|
| Cash & Short-Term Investments | 2.89 | 4.71 | 6.5 | 16.5 | 15.42 | 0.69 | Upgrade
|
| Cash Growth | -57.85% | -27.64% | -60.58% | 7.01% | 2129.27% | -60.28% | Upgrade
|
| Other Receivables | - | - | - | 0.07 | 0.23 | - | Upgrade
|
| Receivables | - | - | - | 0.07 | 0.23 | - | Upgrade
|
| Prepaid Expenses | 1.95 | 0.93 | 1.88 | 1.76 | 0.55 | 0.32 | Upgrade
|
| Total Current Assets | 4.84 | 5.63 | 8.39 | 18.33 | 16.2 | 1.01 | Upgrade
|
| Property, Plant & Equipment | 0.1 | 0.15 | 0.23 | 0.07 | 0.16 | 0.23 | Upgrade
|
| Other Intangible Assets | - | - | - | 8.06 | 8.85 | 9.64 | Upgrade
|
| Other Long-Term Assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Total Assets | 4.94 | 5.79 | 8.62 | 26.46 | 25.21 | 10.88 | Upgrade
|
| Accounts Payable | 0.71 | 0.31 | 0.33 | 0.22 | 0.32 | 0.08 | Upgrade
|
| Accrued Expenses | 0.41 | 0.15 | 0.4 | 0.28 | 0.23 | 0.24 | Upgrade
|
| Short-Term Debt | - | - | - | - | - | 0.8 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | 0.12 | - | Upgrade
|
| Current Portion of Leases | 0.09 | 0.08 | 0.08 | 0.07 | 0.09 | 0.08 | Upgrade
|
| Other Current Liabilities | - | 0.19 | 0.19 | 0.4 | 0.47 | 0 | Upgrade
|
| Total Current Liabilities | 1.22 | 0.73 | 1 | 0.97 | 1.22 | 1.19 | Upgrade
|
| Long-Term Debt | - | - | - | - | 0.04 | - | Upgrade
|
| Long-Term Leases | 0 | 0.07 | 0.15 | 0.01 | 0.08 | 0.15 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | - | 0.53 | 1.53 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 0.4 | - | Upgrade
|
| Total Liabilities | 1.22 | 0.8 | 1.15 | 0.98 | 2.27 | 2.87 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 88.51 | 80.66 | 72.02 | 62.31 | 48.33 | 18.99 | Upgrade
|
| Retained Earnings | -84.49 | -75.37 | -64.25 | -36.82 | -25.4 | -10.98 | Upgrade
|
| Treasury Stock | -0.3 | -0.3 | -0.3 | - | - | - | Upgrade
|
| Comprehensive Income & Other | - | - | - | - | - | 0 | Upgrade
|
| Shareholders' Equity | 3.72 | 4.99 | 7.47 | 25.49 | 22.94 | 8.01 | Upgrade
|
| Total Liabilities & Equity | 4.94 | 5.79 | 8.62 | 26.46 | 25.21 | 10.88 | Upgrade
|
| Total Debt | 0.1 | 0.15 | 0.23 | 0.08 | 0.33 | 1.03 | Upgrade
|
| Net Cash (Debt) | 2.79 | 4.56 | 6.27 | 16.42 | 15.09 | -0.34 | Upgrade
|
| Net Cash Growth | -58.22% | -27.39% | -61.79% | 8.82% | - | - | Upgrade
|
| Net Cash Per Share | 1.10 | 3.47 | 7.79 | 21.44 | 40.24 | -1.22 | Upgrade
|
| Filing Date Shares Outstanding | 3.27 | 2.86 | 1.23 | 0.79 | 0.78 | 0.28 | Upgrade
|
| Total Common Shares Outstanding | 3.27 | 1.29 | 0.8 | 0.79 | 0.71 | 0.27 | Upgrade
|
| Working Capital | 3.62 | 4.9 | 7.39 | 17.36 | 14.98 | -0.18 | Upgrade
|
| Book Value Per Share | 1.14 | 3.88 | 9.32 | 32.44 | 32.34 | 29.21 | Upgrade
|
| Tangible Book Value | 3.72 | 4.99 | 7.47 | 17.43 | 14.09 | -1.63 | Upgrade
|
| Tangible Book Value Per Share | 1.14 | 3.88 | 9.32 | 22.19 | 19.87 | -5.94 | Upgrade
|
| Machinery | - | - | - | - | 0.01 | 0.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.